BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Trevena to Release Third Quarter 2023 Financial Results on November 14, 2023

  Trevena, Inc. announced that it will release its financial results for the third quarter ended September 30, 2023, prior to the market open on Tuesday, November 14, 2023.

  November 9, 2023

   · 

  2 min read
• Business

  Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates

  Avalo Therapeutics, Inc., announced business updates and financial results for the third quarter of 2023.

  November 9, 2023

   · 

  11 min read
• Business

  Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

  Cabaletta Bio, Inc. reported financial results for the third quarter ended September 30, 2023, and provided a business update.

  November 9, 2023

   · 

  13 min read
• Genetown

  Eccogene Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule GLP-1 Receptor Agonist ECC5004 for Cardiometabolic Diseases

  Eccogene announced that it entered into an exclusive license agreement with AstraZeneca under which AstraZeneca will develop and commercialize Eccogene’s small molecule GLP-1 receptor agonist ECC5004 for the potential treatment of obesity, type-2 diabetes and other comorbidities.

  November 9, 2023

   · 

  3 min read
• Business

  Former Amryt Pharma Leadership Team join Poolbeg

  Poolbeg Pharma, a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announces the appointment of key former executives of Amryt Pharma plc to its leadership team.

  November 9, 2023

   · 

  6 min read
• Angle PLC Announces Trading and Business Update

  ANGLE plc, a world-leading liquid biopsy company with innovative circulating tumour cell diagnostic solutions for use in research, drug development and clinical oncology, is providing a trading and business update.

  November 9, 2023

   · 

  5 min read
• Genetown

  invIOs and Dana-Farber Cancer Institute start collaboration to study novel small molecule INV501 for treatment of glioblastoma

  invIOs GmbH, a privately held biotechnology company developing novel therapies for cancer, and Dana-Farber Cancer Institute have entered into a preclinical research collaboration to evaluate invIOs’ small molecule INV501 as a potential treatment for glioblastoma.

  November 9, 2023

   · 

  5 min read
• Business

  EDAP Announces Third Quarter 2023 Financial Results

  EDAP TMS SA, the global leader in robotic energy-based therapies, reported unaudited financial results for the third quarter ending September 30, 2023.

  November 9, 2023

   · 

  19 min read
• BioMidwest

  Biodesix to Participate in Two Upcoming Investor Conferences in November 2023

  Biodesix, Inc. announced Scott Hutton, Chief Executive Officer, will participate in two upcoming investor conferences.

  November 9, 2023

   · 

  3 min read
• Biotech Bay

  Annexon Biosciences to Participate in 2023 Jefferies London Healthcare Conference

  Annexon, Inc. announced that Douglas Love, president and chief executive officer, will participate in a fireside chat during the 2023 Jefferies London Healthcare Conference on Wednesday, November 15, 2023 at 10:30 a.m. GMT in London.

  November 9, 2023

   · 

  1 min read